KLF2-Mediated Modulation of oxidative stress and pyroptosis by Vanillic acid in intervertebral disc degeneration
Biochemical Pharmacology · 2026
DOI: 10.1016/j.bcp.2026.117907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Yuhang Gong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang Province, China; Bone development and metabol…. Hauptthemen laut MEDLINE: Kruppel-Like Transcription Factors, Oxidative Stress, Intervertebral Disc Degeneration, Pyroptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Zhejiang Province Basic Public Welfare Research Program, National Key Clinical Specialty Discipline Construction Program of China, Wenzhou Medical University.
Abstract (Originalsprache)
Intervertebral disc degeneration (IDD) is a major contributor to chronic low back pain, yet current treatments primarily offer symptom relief without addressing the underlying pathology. In this study, we demonstrate that vanillic acid (VA), a natural phenolic compound, protects nucleus pulposus (NP) cells from inflammation-induced pyroptosis, oxidative stress, and extracellular matrix (ECM) degradation. VA markedly reduced both intracellular and mitochondrial reactive oxygen species (ROS) levels and inhibited NLRP3 inflammasome-mediated pyroptosis. Transcriptomic analysis identified KLF2 as a significantly upregulated transcription factor in response to VA treatment. Molecular docking suggested a potential structural interaction between VA and KLF2. Mechanistically, KLF2 was found to mediate VA-induced activation of NRF2 signaling, as KLF2 knockdown abolished NRF2 nuclear translocation. In a lumbar instability mouse model of IDD, VA preserved disc structure and ECM integrity, accompanied by increased expression of KLF2 and NRF2 and reduced pyroptosis. These findings indicate that VA attenuates IDD progression by activating the KLF2/NRF2 axis and suppressing the ROS/NLRP3 cascade, and suggest that VA may serve as a potential compound for the development of KLF2-targeting therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang Province, China; Bone development and metabolism research center of Taizhou Hospital, Zhejiang Province, Linhai, Zh…
- Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
Förderung
- Zhejiang Province Basic Public Welfare Research Program
- National Key Clinical Specialty Discipline Construction Program of China
- Wenzhou Medical University
- Medical and Health Research Project of Zhejiang Province
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Gong, Y., Ye, J., Jiang, T., Shao, S., Li, S., Li, Z., Qiu, J., Zheng, X., Zheng, B., Jiang, C., Chen, H., & Hong, Z. (2026). KLF2-Mediated Modulation of oxidative stress and pyroptosis by Vanillic acid in intervertebral disc degeneration. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.117907
Vancouver
Gong Y, Ye J, Jiang T, Shao S, Li S, Li Z, et al. KLF2-Mediated Modulation of oxidative stress and pyroptosis by Vanillic acid in intervertebral disc degeneration. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.117907
BibTeX
@article{Gong2026,
author = {Gong, Yuhang and Ye, Jiajing and Jiang, Ting and Shao, Shengzan and Li, Sijia and Li, Ze and Qiu, Jianxin and Zheng, Xiaohang and Zheng, Binbin and Jiang, Chao and Chen, Haixiao and Hong, Zhenghua},
title = {KLF2-Mediated Modulation of oxidative stress and pyroptosis by Vanillic acid in intervertebral disc degeneration},
journal = {Biochemical Pharmacology},
year = {2026},
doi = {10.1016/j.bcp.2026.117907}
}
EUVIMED